Comparing the Efficacy and Safety of Three Dose Regimens of BioChaperone PDGF-BB to Becaplermin Gel For the Treatment of Diabetic Foot Ulcer
Phase of Trial: Phase I/II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Becaplermin (Primary) ; Becaplermin
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Virchow Group
- 26 Apr 2012 Results will be presented at the European Wound Management Association in May 2012 and the World Union of Wound Healing Societies in September 2012.
- 28 Feb 2012 The trial enrolled 198 patients, according to an Adocia media release.
- 28 Feb 2012 Status changed from recruiting to completed, according to an Adocia media release.